XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive loss
Non-controlling interests
Treasury shares
Total
Beginning Balance at Dec. 31, 2018 $ 26,792 $ 14,101,689 $ 155,931,770 $ 1,230,511 $ (165,409,890) $ (1,498,940) $ 11,977 $ (4,066,610) $ 327,299
Beginning Balance, shares at Dec. 31, 2018 26,791,684             (144,206)  
Net (loss) profit (2,787,392) (19,941) (2,807,333)
Capital contribution from non-controlling interests of a subsidiary 56,704 56,704
Share-based compensation for employee and director stock awards 18,219   18,219
Common stock issued to investors $ 5,098 5,194,902   5,200,000
Common stock issued to investors, shares 5,098,040                
Foreign currency translation adjustment 163,687 (2,362) 161,325
Ending Balance at Mar. 31, 2019 $ 31,890 14,101,689 161,144,891 1,230,511 (168,197,282) (1,335,253) 46,378 $ (4,066,610) 2,956,214
Ending Balance, shares at Mar. 31, 2019 31,889,724             (144,206)  
Beginning Balance at Dec. 31, 2019 $ 53,222 14,101,689 180,208,610 1,230,511 (176,177,413) (1,744,730) 52,777 $ (4,066,610) 13,658,056
Beginning Balance, shares at Dec. 31, 2019 53,220,902             (144,206)  
Net (loss) profit (2,359,981) 5,870 (2,354,111)
Share-based compensation for employee and director stock awards 300,135   300,135
Common stock issued to investors $ 368 199,632 200,000
Common stock issued to investors, shares 367,897                
Foreign currency translation adjustment (301,215) (830) (302,045)
Ending Balance at Mar. 31, 2020 $ 53,590 $ 14,101,689 $ 180,708,377 $ 1,230,511 $ (178,537,394) $ (2,045,945) $ 57,817 $ (4,066,610) $ 11,502,035
Ending Balance, shares at Mar. 31, 2020 53,588,799             (144,206)